Prof. Luca Iaccarino is an Associate Professor of Rheumatology at the University of Padova, Italy. From August 1st, 2007, to November 30th, 2010, he performed in- and out-patient activity at Ospedale Cà Foncello, Treviso, Italy, and from December 1st, 2010, at Azienda Ospdaliera/University of Padova, Italy. Since 2004, he has been a member of the Italian Society of Rheumatology. The unit in which he was trained and now works is a third-referral rheumatological center of prominence within Italy for the diagnosis and management of patients affected with systemic rheumatic diseases. In addition, he has great experience in the clinical management of connective tissue disease patients and the management and follow-up of pregnant patients with systemic rheumatic diseases. Since 2017, he has been Disease Coordinator in the European Reference Network (ERN) ReCONNET for IgG4-RD and, since 2022, for UCTD. Prof. Luca Iaccarino’s roughly140 scientific publications are highly acknowledged. They include (i) clinical studies describing new manifestations or subgroups of autoimmune disorders, prognostic risk factors, diagnostic tests, and therapeutic interventions, including National Registries on the use of biological drugs in patients with systemic lupus erythematosus; and (ii) immunochemical studies evaluating autoantigens' autoantibodies, epitopes, and complementary epitopes. He has authored or co-authored over 200 proceedings or abstracts at national and international conferences.
Prof. Luca Iaccarino is an Associate Professor of Rheumatology at the University of Padova, Italy. From August 1st, 2007, to November 30th, 2010, he performed in- and out-patient activity at Ospedale Cà Foncello, Treviso, Italy, and from December 1st, 2010, at Azienda Ospdaliera/University of Padova, Italy. Since 2004, he has been a member of the Italian Society of Rheumatology. The unit in which he was trained and now works is a third-referral rheumatological center of prominence within Italy for the diagnosis and management of patients affected with systemic rheumatic diseases. In addition, he has great experience in the clinical management of connective tissue disease patients and the management and follow-up of pregnant patients with systemic rheumatic diseases. Since 2017, he has been Disease Coordinator in the European Reference Network (ERN) ReCONNET for IgG4-RD and, since 2022, for UCTD. Prof. Luca Iaccarino’s roughly140 scientific publications are highly acknowledged. They include (i) clinical studies describing new manifestations or subgroups of autoimmune disorders, prognostic risk factors, diagnostic tests, and therapeutic interventions, including National Registries on the use of biological drugs in patients with systemic lupus erythematosus; and (ii) immunochemical studies evaluating autoantigens' autoantibodies, epitopes, and complementary epitopes. He has authored or co-authored over 200 proceedings or abstracts at national and international conferences.